Clinical trial
Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)
NCT00043849 is registered in ClinicalTrials.gov with National Institute on Aging (NIA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)
- Lead sponsor
- National Institute on Aging (NIA)
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2002
- Completion date
- June 30, 2005
- Enrollment
- 60
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.